Literature DB >> 378994

Hemoglobin switching in sheep. Synthesis, cloning, and characterization of DNA sequences coding for the beta B, beta C, and gamma-globin mRNAs.

E J Benz, P J Kretschmer, C E Geist, J A Kantor, P H Turner, A W Nienhuis.   

Abstract

Synthetic double-stranded DNAs (sDNAs) were prepared from sheep globin mRNA templates isolated from reticulocytes producing either hemoglobin B (HbB) (alpha 2 beta B2), HbC (alpha 2 beta C2), or HbF (alpha 2 gamma 2). These DNAs were inserted into the Eco RI site of plasmid pMB9 by the homopolymer tailing method and used to transform Escherichia coli X1776 to tetracycline resistance. Recombinant clones were identified by colony hybridization and further characterized by molecular hybridization and restriction endonuclease analysis. All plasmids analyzed thus far contained either beta- or gamma-globin DNA sequences. Moreover, sDNAs used for cloning yielded restriction endonuclease fragments consistent with the presence of predominantly beta- or gamma-sDNA, indicating that formation of double-stranded alpha-sDNA proceeds much less efficiently under our conditions than the formation of non-alpha-sDNAs. Three recombinant plasmids, pS beta B2, pS beta C69, and pS gamma 56, were selected for detailed study. These were shown to contain, respectively, beta B-, beta C-, and gamma-DNA sequences by molecular hybridization and by protection of the appropriate cDNAs from S1 nuclease digestion. Each contained all of the restriction endonuclease sites defined for the synthetic sDNAs and protected at least 90% of the sequence length of homologous cDNA. Restriction endonuclease maps of the beta B- and beta C-globin genes were identical at all 12 sites that were mapped, whereas four differences were identified in the gamma gene compared to the two others; three of these corresponded to differences in amino acid sequence of the globins. A method was developed to isolate the anti-mRNA strand of the insert for use as a specific molecular hybridization probe analogous to complementary DNA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Glucocorticoids antagonize induction of prolactin-gene expression by calcitriol in rat pituitary tumour cells.

Authors:  J D Wark; V Gurtler
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

2.  Replication and expression of thymidine kinase and human globin genes microinjected into mouse fibroblasts.

Authors:  W F Anderson; L Killos; L Sanders-Haigh; P J Kretschmer; E G Diacumakos
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Cloning and characterization of DNA sequences surrounding the human gamma-, delta-, and beta-globin genes.

Authors:  R E Kaufman; P J Kretschmer; J W Adams; H C Coon; W F Anderson; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

4.  A family of long reiterated DNA sequences, one copy of which is next to the human beta globin gene.

Authors:  J W Adams; R E Kaufman; P J Kretschmer; M Harrison; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

5.  DNA methylation in chicken alpha-globin gene expression.

Authors:  L S Haigh; B B Owens; O S Hellewell; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  Increased level of prolactin gene sequences in bromodeoxyuridine treated GH cells.

Authors:  D K Biswas; S D Hanes
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

7.  Mechanism of induction of prolactin synthesis in GH cells.

Authors:  D K Biswas; S D Hanes; B A Brennessel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Three mouse models of human thalassemia.

Authors:  J Martinell; J B Whitney; R A Popp; L B Russell; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.